Clinical Trials Browser

NCT04400695 2024-01-24

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

Phase 3 Unknown

366 enrolled

Breast

Breast Neoplasms

NCT06152471 2023-11-30

ASF-BC

Phase 3 Unknown

100 enrolled

Breast

Breast Neoplasms, Diarrhea, Drug-Related Side Effects and Adverse Reactions

NCT03926091 2023-11-14

CLOVER

Phase 3 Unknown

2,172 enrolled

Breast

Breast Neoplasms

NCT05673629 2023-11-08

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

Phase 3 Unknown

552 enrolled

Breast

Breast Neoplasms

NCT05144867 2023-10-17

SRSvsWBRT

Phase 3 Unknown

98 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT05755048 2023-09-01

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

Phase 3 Unknown

314 enrolled

Breast

Breast Neoplasms

NCT05433480 2023-07-27

A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer

Phase 3 Unknown

274 enrolled

Breast

Breast Neoplasms

NCT01579734 2023-06-28

HOT

Phase 3 Unknown

1,884 enrolled

Breast

Breast Neoplasms

NCT03613181 2023-04-24

ANGLeD

Phase 3 Unknown

150 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

NCT05790096 2023-03-29

Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy

Phase 3 Unknown

60 enrolled

Breast

Breast Neoplasms

NCT00412022 2023-03-24

HOBOE

Phase 3 Unknown

1,294 enrolled

Breast

Breast Neoplasms

NCT05728632 2023-02-23

CONTROL

Phase 3 Unknown

80 enrolled

BreastLymphoid

Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse, Ventricular Dysfunction, Left, Cardiotoxicity

NCT05637671 2023-02-08

Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms

Phase 3 Unknown

146 enrolled

Breast

Breast Neoplasms, Hot Flashes

NCT02914158 2023-01-17

ASPAIT

Phase 3 Unknown

680 enrolled

Breast

Breast Neoplasms

NCT05670054 2023-01-04

Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients

Phase 3 Unknown

116 enrolled

Breast

Breast Neoplasms

NCT03863223 2022-11-23

A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer

Phase 3 Unknown

590 enrolled

Breast

Breast Neoplasms

NCT00887380 2022-11-18

STARS

Phase 3 Unknown

2,023 enrolled

Breast

Breast Neoplasms

NCT05346861 2022-04-26

Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab

Phase 3 Unknown

240 enrolled

Breast

Breast Neoplasms

NCT01547741 2022-04-14

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Phase 3 Unknown

1,871 enrolled

Breast

Breast Neoplasms

NCT02236806 2022-02-01

SAFE

Phase 3 Unknown

262 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT00212121 2022-01-21

Radiation Dose Intensity Study in Breast Cancer in Young Women

Phase 3 Unknown

2,400 enrolled

Breast

Breast Neoplasms

NCT05164952 2021-12-21

Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole

Phase 3 Unknown

50 enrolled

Breast

Breast Neoplasms

NCT04047758 2021-07-20

Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer

Phase 3 Unknown

420 enrolled

Breast

Breast Neoplasms

NCT03980054 2021-05-24

A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

Phase 3 Unknown

1,192 enrolled

Breast

Breast Neoplasms

NCT04803266 2021-03-17

Elective Internal Mammary Node Irradiation in Women With Node-positive Breast Cancer

Phase 3 Unknown

747 enrolled

Breast

Breast Neoplasms

NCT04665986 2020-12-14

Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer

Phase 3 Unknown

50 enrolled

Breast

Breast Neoplasms

NCT01917279 2020-07-23

CAMELLIA

Phase 3 Unknown

280 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Skin Diseases

NCT04307147 2020-03-13

NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy

Phase 3 Unknown

316 enrolled

Breast

Breast Neoplasms

NCT01758146 2020-03-04

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

Phase 3 Unknown

412 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT00541086 2020-02-07

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

Phase 3 Unknown

3,697 enrolled

Breast

Breast Neoplasms

NCT03544762 2019-05-30

breast

Phase 3 Unknown

60 enrolled

Breast

Breast Neoplasms

NCT03949634 2019-05-14

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

Phase 3 Unknown

272 enrolled

Breast

Breast Neoplasms

NCT00532727 2019-02-20

TNT

Phase 3 Unknown

400 enrolled

Breast

Breast Neoplasms

NCT02751606 2018-12-06

Nano MRI on 7 Tesla in Rectal and Breast Cancer

Phase 3 Unknown

30 enrolled

BreastGastrointestinal

Breast Neoplasms, Rectal Neoplasms

NCT03731026 2018-11-06

The LightPath® and 68Ga-RM2 in Breast Cancer Study

Phase 3 Unknown

80 enrolled

Breast

Breast Neoplasms

NCT03137368 2018-10-31

STEP

Phase 3 Unknown

300 enrolled

Breast

Breast Neoplasms

NCT01104571 2018-09-17

EPHOS-B

Phase 3 Unknown

257 enrolled

Breast

Breast Neoplasms

NCT00301925 2018-08-08

TACT2

Phase 3 Unknown

4,400 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02898376 2018-08-08

FIBROTHERME

Phase 3 Unknown

142 enrolled

Breast

Breast Neoplasms, Fibrosis

NCT01710605 2018-04-09

Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

Phase 3 Unknown

800 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT03404752 2018-01-19

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Phase 3 Unknown

120 enrolled

Breast

Breast Neoplasms, Neutropenia

NCT02769104 2018-01-09

ACCN

Phase 3 Unknown

120 enrolled

Breast

Breast Neoplasms

NCT03359694 2017-12-02

Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer

Phase 3 Unknown

300 enrolled

Breast

Breast Neoplasms, Genetic Predisposition to Disease

NCT03351062 2017-11-22

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

Phase 3 Unknown

844 enrolled

Breast

Breast Neoplasms

NCT03319069 2017-10-24

Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer

Phase 3 Unknown

60 enrolled

Breast

Breast Neoplasms

NCT00408408 2017-09-18

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Phase 3 Unknown

1,206 enrolled 19 charts

Breast

Breast Neoplasms

NCT01222052 2017-06-26

NNBC3-Europe

Phase 3 Unknown

4,150 enrolled

Breast

Breast Neoplasms

NCT02761460 2017-06-01

The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia

Phase 3 Unknown

338 enrolled

Breast

Breast Neoplasms

NCT01642771 2017-04-19

Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer

Phase 3 Unknown

636 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03006614 2017-01-16

PERS

Phase 3 Unknown

320 enrolled

Breast

Breast Neoplasms